LMAT Dividend History & Description — LeMaitre Vascular Inc
LeMaitre Vascular provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease, end-stage renal disease, and to a lesser extent cardiovascular disease. Co.'s portfolio of devices consists of products that are used in arteries and veins. Co.'s product offerings include a suite of biologic products, which include the XenoSure patch (bovine pericardium), CardioCel and VascuCel patches (bovine pericardium), ProCol graft (bovine mesenteric vein), Artegraft (bovine carotid artery), Omniflow II biosynthetic graft (ovine tissue and synthetic mesh) and the RestoreFlow Allograft cryopreserved graft (human cadaver tissue). When considering the LeMaitre Vascular Inc stock dividend history, we have taken known splits into account, such that the LMAT dividend history is presented on a split-adjusted ("apples to apples") basis. LeMaitre Vascular Inc dividend history is presented both in graphical/chart form, and as a LMAT dividend history data table along the right-hand column.